Motosol (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Motosol, is a mucolytic presented as an oral formulation for oral use. It helps to thin and loosen thick bronchial secretions, facilitating their removal in patients with respiratory conditions such as bronchitis, COPD and upper respiratory tract infections.

GNH USA supplies Motosol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ambroxol Hydrochloride acts on the respiratory mucosa to improve clearance of viscous secretions. - Acute bronchitis: loosens thick mucus, aiding expectoration and symptom relief. - Chronic bronchitis: reduces sputum viscosity, supporting long‑term airway clearance. - Chronic obstructive pulmonary disease (COPD): facilitates removal of bronchial secretions, helping to ease cough. - Upper respiratory tract infections: promotes drainage of mucus, reducing congestion and cough frequency.

Ambroxol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Taste disturbance: altered or bitter taste in the mouth. - Nausea or vomiting: mild gastrointestinal upset. - Abdominal discomfort: occasional stomach pain or cramps. - Skin rash: mild erythema or itching. - Dizziness: transient light‑headedness. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Allergic reactions: swelling, hives, or difficulty breathing. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Eosinophilia: elevated eosinophil count in blood. - Anaphylaxis: rapid onset of systemic allergic response. - Hepatic dysfunction: abnormal liver enzyme elevations. - Hematologic abnormalities: rare cases of leukopenia or thrombocytopenia.

Before using Ambroxol, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: weigh potential benefits against possible risks. - Renal impairment: dose adjustment may be required in reduced kidney function. - Asthma: monitor for possible bronchospasm, especially in severe disease. - Drug interactions: review all concomitant medications with a pharmacist. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ambroxol may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Combined use with other mucolytics: may increase risk of excessive mucus thinning. - Anticholinergic agents: can diminish the secretory effect of ambroxol.

Moderate Interactions (Monitor Closely): - Bronchodilators (e.g., salbutamol): may have additive respiratory effects. - Antibiotics for respiratory infections: monitor for enhanced cough suppression. - Antihistamines: possible alteration of mucosal secretions. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): watch for gastrointestinal irritation. - Herbal products containing expectorants: assess cumulative mucolytic activity.